{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "adds_modification",
    "modifications" : [ {
      "modification_type" : "hydroxylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01984",
      "entity_text" : "Mycinamicin",
      "entity_type" : "protein"
    },
    "is_direct" : true,
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:O14649",
      "entity_text" : "task",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "(iii) MycCI was employed due to its characterised task to hydroxylate this position in the Mycinamicin biosynthetic pathway, and its unusual substrate flexibility.119 Unfortunately, the sequential application of P450s JuvD and MycCI on either one of compounds 20-22 was not reported, and neither was that of TyII on any of compounds 23, 24, 26 and 27.",
  "reading_complete" : "2020-08-03T12:12:51Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T12:09:17Z",
  "evidence" : [ "task to hydroxylate this position in the Mycinamicin" ],
  "pmc_id" : "6686969",
  "score" : 0
}